Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dove

Showing results (131-140 of 179) with videos related to

Pageof 18
Sort By:
The American Journal of Gastroenterology|May 31, 2017
Corrigendum: Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide UseBrian E Lacy, William D Chey, Brooks D Cash, et al.
Health Care Analysis : HCA : Journal of Health Philosophy and Policy|September 2, 2019
Co-production and Managing Uncertainty in Health Research Regulation: A Delphi StudyIsabel Fletcher, Stanislav Birko, Edward S Dove, et al.
The American Journal of Gastroenterology|April 19, 2017
Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide UseBrian E Lacy, William D Chey, Brooks D Cash, et al.
American Journal of Public Health|September 25, 2010
The impact of Massachusetts' smoke-free workplace laws on acute myocardial infarction deathsMelanie S Dove, Douglas W Dockery, Murray A Mittleman, et al.
Journal of Law and the Biosciences|February 5, 2024
Purpose definition as a crucial step for determining the legal basis under the GDPR: implications for scientific researchRegina Becker, Davit Chokoshvili, Adrian Thorogood, et al.
American Journal of Preventive Medicine|November 21, 2018
Racial/Ethnic Differences in the Response to Incentives for Quitline EngagementMaya Vijayaraghavan, Melanie S Dove, Susan L Stewart, et al.
Regulatory Peptides|November 5, 1998
NPY Y1 antagonists: structure-activity relationships of arginine derivatives and hybrid compounds with arpromidine-like partial structuresI Aiglstorfer, A Uffrecht, K Gessele, et al.
Therapeutic Advances in Gastroenterology|April 26, 2019
Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trialsBrian E Lacy, Lucinda A Harris, Lin Chang, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 21, 2016
Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor AntagonistN Levy-Cooperman, G McIntyre, L Bonifacio, et al.
Genome Biology|September 16, 2014
Building a data sharing model for global genomic researchPatricia Kosseim, Edward S Dove, Carman Baggaley, et al.
Pageof 18

Showing results (131-140 of 179) with videos related to

Sort By:
Pageof 18
The American Journal of Gastroenterology|May 31, 2017
Corrigendum: Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide UseBrian E Lacy, William D Chey, Brooks D Cash, et al.
Health Care Analysis : HCA : Journal of Health Philosophy and Policy|September 2, 2019
Co-production and Managing Uncertainty in Health Research Regulation: A Delphi StudyIsabel Fletcher, Stanislav Birko, Edward S Dove, et al.
The American Journal of Gastroenterology|April 19, 2017
Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide UseBrian E Lacy, William D Chey, Brooks D Cash, et al.
American Journal of Public Health|September 25, 2010
The impact of Massachusetts' smoke-free workplace laws on acute myocardial infarction deathsMelanie S Dove, Douglas W Dockery, Murray A Mittleman, et al.
Journal of Law and the Biosciences|February 5, 2024
Purpose definition as a crucial step for determining the legal basis under the GDPR: implications for scientific researchRegina Becker, Davit Chokoshvili, Adrian Thorogood, et al.
American Journal of Preventive Medicine|November 21, 2018
Racial/Ethnic Differences in the Response to Incentives for Quitline EngagementMaya Vijayaraghavan, Melanie S Dove, Susan L Stewart, et al.
Regulatory Peptides|November 5, 1998
NPY Y1 antagonists: structure-activity relationships of arginine derivatives and hybrid compounds with arpromidine-like partial structuresI Aiglstorfer, A Uffrecht, K Gessele, et al.
Therapeutic Advances in Gastroenterology|April 26, 2019
Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trialsBrian E Lacy, Lucinda A Harris, Lin Chang, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 21, 2016
Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor AntagonistN Levy-Cooperman, G McIntyre, L Bonifacio, et al.
Genome Biology|September 16, 2014
Building a data sharing model for global genomic researchPatricia Kosseim, Edward S Dove, Carman Baggaley, et al.
Pageof 18